All | Pre-treated | Treatment-naïve | P value Pre-treated vs. Treatment-naïve | |
---|---|---|---|---|
Numbers (eyes) | 25 | 13 | 12 | |
Age (years) | 67.16±8.20 | 67.2±5.44 | 67.12±10.7 | 0.983 a |
Sex (male: female) | 20: 5 | 9:4 | 11:1 | 0.161b |
Laterality (right: left) | 15: 10 | 7:6 | 8:4 | 0.513b |
Best Corrected Visual acuity | ||||
Snellen | 0.53±0.31 | 0.52±0.33 | 0.54±0.30 | 0.841 a |
ETDRS letters | 65.48±15.43 | 64.46±16.52 | 66.58±14.79 | 0.739 a |
Central macular thickness (μm) | 406.92±159.36 | 356.08±145.58 | 462±160.99 | 0.097 a |
Location of vascular lesion (eyes) | ||||
Subfoveal | 15 (60.0%) | 7 (53.8%) | 8 (66.6%) | 0.566c |
Juxtafoveal | 9 (36.0%) | 5 (38.5%) | 4 (33.3%) | |
Extrafoveal | 1 (4.0%) | 1 (8%) | 0 (0%) | |
Area of branching vascular network (mm2) | 3.12±1.98 | 3.66±2.18 | 2.11±1.02 | 0.045a |
Numbers of polypoidal lesions | 2.60±1.68 | 3.30±1.88 | 1.83±1.02 | 0.025a |
Height of the largest polypoidal lesion (μm) | 345.64±159.44 | 331.84±134.21 | 360.58±187.99 | 0.662 a |
Location of the polyp closest to the foveal center (eyes) | ||||
Subfoveal | 11 (44.0%) | 3 (23.0%) | 8 (66.6%) | 0.004c |
Juxtafoveal | 7 (28.0%) | 3 (23.0%) | 4 (33.3%) | |
Extrafoveal | 7 (28.0%) | 7 (53.8%) | 0 (0%) |